• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
SI-BONE, Inc. - Common Stock
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeuroBo Pharmaceuticals, Inc. - Common Stock (NQ:NRBO)

2.360 UNCHANGED
Last Price Updated: 3:59 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.360
Bid (Size) 2.310 (1)
Ask (Size) 2.680 (17)
Prev. Close 2.360
Today's Range 2.360 - 2.360
52wk Range N/A - N/A
Shares Outstanding 8,616,010
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
December 03, 2024
Via ACCESSWIRE
News headline image
Life Sciences Investor Forum: Presentations Now Available for Online Viewing
November 15, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire

Performance

More News

Read More
News headline image
Life Sciences Investor Forum Agenda Announced for November 14th
November 12, 2024
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
NeuroBo Pharmaceuticals to Present at the November 21st Virtual Investor Summit Microcap Event
November 11, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
October 16, 2024
Via Benzinga
News headline image
NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q2 2024 ↗
August 14, 2024
Via InvestorPlace
News headline image
NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying ↗
June 26, 2024
Via Benzinga
News headline image
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success ↗
May 22, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
May 22, 2024
Via Benzinga
News headline image
NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q1 2024 ↗
May 09, 2024
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
February 29, 2024
Via Benzinga
News headline image
The Top 3 Stocks to Watch This Week ↗
February 05, 2024
Via InvestorPlace
News headline image
Dow Jumps 250 Points; Honeywell Issues Weak Forecast ↗
February 01, 2024
Via Benzinga
Topics Stocks
News headline image
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
February 01, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
February 01, 2024
Via Benzinga
News headline image
Stocks Rise Amid Flood Of Economic Data ↗
February 01, 2024
Via Talk Markets
Topics Economy
News headline image
Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations ↗
February 01, 2024
Via Benzinga
Topics Stocks
NeuroBo Pharmaceuticals Inc. (NASDAQ: NRBO) is One of Thursday Morning’s Most Active Stocks
February 01, 2024
Via Investor Brand Network
News headline image
Why Obesity-Drug Maker NeuroBo Stock Is Trading Higher ↗
February 01, 2024
Via Benzinga
News headline image
Nasdaq Surges 100 Points; US Jobless Claims Increase To 224,000 ↗
February 01, 2024
Via Benzinga
Topics Stocks
News headline image
What's Going On With Clinical-Stage Biotech Firm NeuroBo Shares Today? ↗
December 29, 2023
Via Benzinga
News headline image
Life Science Investor Forum: Presentations Now Available for Online Viewing
December 15, 2023
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Science Investor Forum Agenda Announced for December 14th, 2023
December 12, 2023
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
October 31, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
August 18, 2023
Via Benzinga

Frequently Asked Questions

Is NeuroBo Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, NeuroBo Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does NeuroBo Pharmaceuticals, Inc. - Common Stock trade on?
NeuroBo Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeuroBo Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for NeuroBo Pharmaceuticals, Inc. - Common Stock is NRBO on the Nasdaq Stock Market
What is the current price of NeuroBo Pharmaceuticals, Inc. - Common Stock?
The current price of NeuroBo Pharmaceuticals, Inc. - Common Stock is 2.360
When was NeuroBo Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of NeuroBo Pharmaceuticals, Inc. - Common Stock was at 11/27/24 03:59 PM ET
What is the market capitalization of NeuroBo Pharmaceuticals, Inc. - Common Stock?
The market capitalization of NeuroBo Pharmaceuticals, Inc. - Common Stock is 20.33M
How many shares of NeuroBo Pharmaceuticals, Inc. - Common Stock are outstanding?
NeuroBo Pharmaceuticals, Inc. - Common Stock has 20M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap